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Abstract: Isomeric fluorinated α-bromoenones react with dinucleophilic β-
mercaptoalcohols in CH2Cl2 at room temperature in the presence of Et3N in a multistep 
process. Depending on the position of the CF3 group, different O,S-heterocycles or non-
cyclic products were obtained. Whereas in the case of 3-bromo-1,1,1-trifluorobut-3-en-
2-ones derivatives of 1,4-oxathianes were formed, the isomeric 2-bromo-4,4,4-
trifluorobut-2-en-1-ones yielded 1,3-oxathiolanes or non-cyclic sulfides. The thia-
Michael addition is proposed as the initial step of the reaction, and the final 
heterocyclization is governed by the location of the CF3 group. 
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Graphical abstract-text: β-Mercaptoalcohols react smoothly as binucleophilic agents 
with fluorinated α-bromoenones, and the type of the formed products depends strongly 
on the location of the CF3 group in the enones. Whereas 2-bromo-4,4,4-trifluorobut-2-
en-1-ones yield the corresponding 5-membered 1,3-oxathiolanes or, alternatively, open 
chain sulfides, reactions with isomeric 3-bromo-1,1,1-trifluorobut-3-en-2-ones lead to 
6-membered 1,4-oxathiane derivatives, exclusively.  
 
Introduction 
 
Reactions generally known as Michael addition are widely applied for the synthesis of 
both chiral and achiral organic compounds.[1] Depending on the structure of the Michael 
acceptor and the nucleophilic Michael donor, the reaction leads to diverse acyclic final 
products. Michael reactions with dinucleophiles open access to a plethora of 
heterocycles with diverse ring size and heteroatoms via an addition/heterocyclization 
sequence. 
 The development of methods for the synthesis of fluorinated heterocycles is of 
current interest,[2] and reactions with fluorinated Michael acceptors, especially with α,β-
unsaturated trifluoromethylketones, offers a straightforward approach to this class of 
compounds.[3] In a series of recent publications, reactions of 3-bromo-1,1,1-trifluorobut-
3-en-2-ones with dinucleophiles such as 1,2-diamines and β-aminoalcohols have been 
studied in detail.[4] The formation of piperazine and morpholine derivatives, 
respectively, was explained via a cascade of reaction steps, initiated by the Michael-type 
addition. Moreover, in a recent study, α-bromo(trifluoromethyl)enones were described 
as prone heterodienes, which reacted with α,β-unsaturated aldehydes in the presence of 
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an organocatalyst to give highly substituted fluoroalkylated 3,4-dihydro-2H-pyrans in 
an asymmetric hetero-Diels-Alder reaction.[5a] 
 On the other hand, we reported that electron-rich thiocarbonyl S-methanides 1 
react chemoselectively with isomeric 1,1,1-trifluorobut-3-en-2-ones (2) and 4,4,4-
trifluorobut-2-en-1-ones (3) yielding 1,3-oxathioles 4 or tetrahydrothiophene derivatives 
5, respectively, as products of the [3+2]-cycloaddition (Scheme 1).[5b]  Based on this 
observation, and prompted by results reported by Nenajdenko and collaborators,[4] we 
decided to examine reactions of β-mercaptoalcohols as binucleophilic agents with α-
bromoenones derived from 2 and 3.  
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Scheme 1. Chemoselective [3+2]-cycloadditions of the in situ generated thiocarbonyl S-
methanides 1 with trifluoromethylated α,β-unsaturated ketones 2 and 3. 
 
 Thiols are known as excellent nucleophiles in Michael addition reactions, and 
thiol-Michael additions have been studied extensively. Two recent comprehensive 
reviews summarize its importance in materials chemistry[6] and biological chemistry.[7] 
In the latter case, the thia-Michael addition found application for the detection of thiols 
in living cells.[8] 
 The reactions of non fluorinated α-bromoenones 6 with aliphatic and aromatic 
thiols, performed in the presence of a base, gave either α,β-disulfanyl ketones 7 or α-
sulfanylenones 8 resulting from a sequence of addition and elimination reactions[9] 
(Scheme 2).  
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Scheme 2. Addition-elimination reactions of α-bromoenones 6 with thiols performed in 
the presence of a base. 
 
In a very recent publication we reported on reactions of diverse thiols and 
selenols, including β-mercaptoalcohols, with electron deficient dialkyl 
dicyanofumarates.[10] In these systems, instead of the expected thia-Michael addition, a 
new redox reaction, resulting in the formation of the corresponding disulfides or 
diselenides, respectively, was observed. The course of the reaction was rationalized by a 
SET mechanism, which replaced the expected addition of the reactive R–XH (X = S or 
Se) nucleophile to the C=C bond.   
 
 The goal of the present study was to examine whether the reaction of fluorinated 
α-bromoenones with β-mercaptoalcohols is limited to the Michael addition or 
heterocyclization within the initially formed adduct will lead to fluorinated O,S-
heterocycles. In addition, the influence of the position of the CF3 group on the reaction 
course and the type of the final products should be investigated.  
 
Results and Discussion  
 
Earlier studies with fluorinated α-bromoenones relate to 4-aryl-3-bromo-1,1,1-
trifluorobut-3-en-2-ones 9 exclusively.[4] The isomeric 1-aryl-2-bromo-4,4,4-
trifluorobut-2-en-1-ones 10 were prepared for the present study as a mixture of (E/Z)-
stereoisomers from enones 3[5b] via a bromination/dehydrobromination procedure. An 
alternative method for its preparation was a multistep reaction starting with 2-bromo-
3,3,3-trifluoropropene leading to (E)-configured enones 3, which subsequently were 
converted to (E)-10.  
 In a test experiment, α-bromoenone 9a was reacted with mercaptoethanol (11a) in 
CH2Cl2 solution in the presence of an excess of Et3N at r.t. The TLC control showed 
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that the reaction was complete after 48 h. The chromatographic separation led to a 
colorless solid. The 1H-NMR spectrum showed four characteristic signals at 4.18, 4.02, 
3.20 and 2.86 ppm, corresponding to a CH2O and a CH2S group. In the 13C-NMR 
spectrum, these groups absorbed at 60.1 and 28.7 ppm, respectively. Two quartets found 
at 122.2 (1ЈC,F = 285.0 Hz) and 96.7 ppm (2ЈC,F = 31.5 Hz) were attributed to a CF3–C 
unit. Correlation analysis allowed to identify an olefinic unit C=CH by the presence of 
two signals at 123.0 and 128.3 ppm. The strong IR absorption at 3379 cm–1 indicated 
the presence of an OH group. Finally, the ESI-MS showed a peak at m/z 275.2 (100%), 
which corresponded to [M+1]+ for C12H10F3O2S. Based on these data, the structure of 
the obtained compound corresponded to a 1:1-adduct after elimination of HBr and could 
be formulated as 1,4-oxathiane derivative 12a, most likely with (Z)-configuration of the 
C=C bond (Scheme 3).  
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Scheme 3. Reactions of α-bromoenones 9 with β-mercaptoalcohols 11 to give 1,4-
oxathiane derivatives 12. 
 
 Using the same reaction conditions, α-bromoenone 9a was reacted with β-
mercaptoalcohols 11b–d, and in all cases the corresponding 1,4-oxathianes 12b–d were 
isolated as sole products in variable yields (49–15%). In all three cases the isolated 
material consisted of a mixture of two diastereoisomers for which the d.r. values were 
determined in a range of 96:4 to 90:10 based on the registered 19F NMR spectra. All 
attempts to separate these mixtures, including semi-preparative flash chromatography, 
were unsuccessful. In addition, enones 9b,c with a 4-chlorophenyl and 4-
methoxyphenyl group, respectively, and 11a gave the expected products of type 12. In 
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the case of 9c, the yield of the isolated product 12f was low (17%). The 
chromatographic separation of the reaction mixture delivered, along with the desired 
product 12f, a comparable amount of an oily material, which, according to the registered 
spectra, consisted of a mixture of non-identified compounds. 
 In order to compare the influence of the CF3 group, mercaptoethanol 11a was 
tested in the reaction with α-bromoenone 10a, which is an isomer of 9a, under the same 
conditions (CH3Cl2, Et3N, r.t.). In that case, the product was obtained as an oily 
material. The 1H NMR spectrum revealed the presence of three CH2 groups, registered 
as two multiplets at 4.29–4.19 and 3.15–3.06 ppm and a singlet at 3.65 ppm. In the 13C 
NMR spectrum, an absorption at 194.1 ppm was attributed to a ketone C=O group, 
evidenced by a strong absorption at 1698 cm–1 in the IR spectrum. Again, two signals at 
124.9 (1JC,F = 289.5 Hz) and 92.0 ppm (2JC,F = 30.0 Hz) were attributed to a CF3–C 
fragment. The ESI-MS showed the [M+1]-peak at m/z 277.1 (85%). Also in that case, 
the structure of the product corresponded with that of the initial 1:1-adduct after 
elimination of HBr and subsequent heterocyclization. Thus, it can be formulated as the 
1,3-oxathiolane derivative 13 (Scheme 4).  
When the reaction of 11a was performed with 10b, bearing a 4-methoxyphenyl 
substituent, another reaction course was observed, and the sulfide 14a was isolated in 
76% yield. The structure of this compound was elucidated on the basis of its 
spectroscopic data. In addition, the same type of sulfide, 14b, was obtained in 34% yield 
when 10a was reacted with 11c. Also in this case, the isolated product was identified as 
an inseparable mixture of two diastereoisomers in a ratio ca.1:1 (19F NMR).  
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Scheme 4. Reactions of α-bromoenones 10 with β-mercaptoalcohols 11a,c  
 The obtained results demonstrate that the position of the CF3 group in the α-
bromoenones determines the reaction course and the type of the resulting product. A 
plausible mechanistic pathway leading to the 1,3-oxathianes 12 is presented in Scheme 
5. The initial step of the reaction sequence comprises the thia-Michael addition to give 
15, which easily undergoes the intramolecular nucleophilic substitution leading to the 
thiiranium salt 16. The latter intermediate undergoes deprotonation and simultaneous 
thiirane ring opening. The resulting capto-dative olefin 17 forms the heterocyclic 
product 12 via an intramolecular acetalization. The last step corresponds with the well-
known tendency of fluorinated aldehydes and ketones to form stable hydrates and 
hemiacetals. An alternative formation of 17 can be proposed via addition of 11a to 16 to 
give 18, and subsequent elimination of 11a. No attempts were made to evidence the 
appearance of the thiiranium cation 16 but analogous intermediates are frequently 
postulated in reactions of β-halogen-substituted sulfides or thiols[9] with nucleophiles 
(so called ‘neighbouring group participation’). However, in a recent study, the 
attempted NMR detection of an intermediate of that type was completely 
unsuccessful.[11] 
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Scheme 5. Proposed reaction mechanism for the formation of 1,4-oxathianes 12. 
 
 The explanation of the reaction pathway leading to 1,3-oxathiolane 13 from α-
bromoenone 10a and 11a via the Michael adduct 19 as key intermediate is based on the 
assumption that after elimination of HBr the α,β-unsaturated ketone 20 is formed 
(Scheme 6). The latter undergoes preferably the heterocyclization leading to the 1,3-
oxathiolane 13. On the other hand, the formation of sulfides 14 can be rationalized by 
intramolecular substitution of the Br atom (SNi(Hal))[12] in 19. This step leads to the 
zwitterionic intermediate 21, which reacts with water to give 14. 
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Scheme 6. Reaction mechanisms for the formation of 1,3-oxathiolane 13 and sulfides 
14. 
 
Conclusions 
 
The presented study shows that in addition to 1,2-diamines and β-aminoalcohols, β-
mercaptoalcohols are useful dinucleophiles for exploration in reactions with fluorinated 
α-bromoenones as superior Michael acceptors. The comparison of the results obtained 
with isomeric fluorinated butenones demonstrates that the CF3 group governs the 
reaction course. In both systems studied, the initially formed thia-Michael adducts 
undergo further transformations, and in both reaction pathways, the final 
heterocyclization occurs via intramolecular nucleophilic attack of the OH group at the 
electrophilic sp2-C-atom bearing the activating CF3 group. In two of the studied cases, 
the initially formed Michael adducts undergo an intramolecular halogen-substitution, 
which is a competitive process of the sequence HBr-elimination/cyclization.  
The presented results open straightforward ways for the synthesis of very little known 
fluoroalkylated 1,4-oxathianes and 1,3-oxathiolanes. Diverse compounds derived from 
both systems have extensively been studied as biologically active compounds [13a-e-
new;] and some applications of ligands derived from 1,3-oxathianes in asymmetric 
synthesis are also reported [13f-new].  
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Experimental Section 
 
General Remarks: All reactions were carried out in oven-dried glassware under inert 
atmosphere (N2), CH2Cl2 was dried over CaH2 and distilled prior to use. Column 
chromatography purifications were performed with silica gel 60 (230-400 mesh). Thin 
layer chromatography was carried out on TLC plates (silica gel 60 F254). 1H NMR (600 
MHz) and 13C NMR spectra (150 MHz) were recorded in CDCl3 using a Bruker Avance 
III 600 spectrometer. 19F NMR spectra (188 MHz) were recorded on Varian Gemini 200 
spectrometer. NMR signals were referenced to residual non-deuterated solvent signals 
(7.26 ppm for 1H, 77.0 ppm for 13C). The abbreviations used are: s (singlet), d (doublet), 
dd (doublet of doublet), m (multiplet), b (broad). IR spectra were measured using a 
NEXUS FT-IR spectrophotometer (as film or KBr pellets). The ESI-MS spectra were 
obtained using a Varian 500 MS LS Ion Trap spectrometer. HRMS (ESI) were 
registered using a GCT Premier Waters instrument.  
 
Starting materials 
 
Commercially available solvents and mercaptoethanol (11a) were used. β-
Mercaptoalcohols 11b–d were synthesized according to ref.[13] The fluorinated β-
bromoenones of type 9[14] and 10[15] were prepared based on the published procedures.  
 
Synthesis of 4-aryl-1,1,1-trifluorobut-3-en-2-ones 2 
General procedure: Trifluoroacetone (2.0 g, 17.8 mmol) was added to the solution of an 
appropriate aromatic aldehyde (4.40 mol), acetic acid (400 mg, 6.67 mmol) and 
piperidine (300 mg, 3.53 mmol) in anhydrous toluene while cooling the reaction flask in 
an ice-bath (0° C). The reaction mixture was left over night and was then diluted with 
CH2Cl2 (~10 ml) and a saturated aqueous solution of NH4Cl. The organic layer was 
separated and the water phase was washed with CH2Cl2 (3x10 ml). The combined 
organic layers were dried over anhydrous Na2SO4, filtrated, and finally the solvents 
were removed under reduced pressure. The crude products were purified on an 
automatic flash chromatography system on SiO2 columns with mixtures of petroleum 
ether with increasing amounts of CH2Cl2 (0–5%) as an eluent. 
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4-Phenyl-1,1,1-trifluorobut-3-en-2-on (2a).[5] Yield: 449 mg (51%); yellow oil. 1H 
NMR (600 MHz, CDCl3): δ 7.97 (d, 3JH,H = 16.0 Hz, 1H, CH), 7.65–7.64 (m, 2 arom. 
CH), 7.50–7.44 (m, 3 arom. CH), 7.02 (d, 3JH,H = 16.0 Hz, 1H, CH) ppm. 
 
4-(4-Chlorophenyl)-1,1,1-trifluorobut-3-en-2-on (2b).[16] Yield: 485 mg (47%); yellow 
crystals, m.p. 62.4–63.5 ºC (without crystallization) (lit.[16a], m.p. 43−46 °C). 1H NMR 
(600 MHz, CDCl3): δ 7.92 (d, 3JH,H = 16.0 Hz, 1H, CH), 7.59–7.57 (m, 2 arom. CH), 
7.44–7.43 (m, 2 arom. CH), 6.99 (d, 3JH,H = 16.0 Hz, 1H, CH) ppm. 
 
4-(4-Methoxyphenyl)-1,1,1-trifluorobut-3-en-2-on (2c).[5] Yield: 314 mg (31%); yellow 
semi-solid, m.p.  54.3–55.5 ºC. 1H NMR (600 MHz, CDCl3): δ 7.94 (d, 3JH,H = 15.8 Hz, 
1H, CH), 7.61–7.60 (m, 2 arom, CH), 6.96–6.95 (m, 2 arom. CH), 6.89 (d, 3JH,H = 15.8 
Hz, 1H, CH), 3.87 (s, 3H, CH3) ppm. 
 
Synthesis of 4-aryl-3-bromo-1,1,1-trifluorobut-3-en-2-ones 9 
General procedure: A solution of Br2 (240 mg, 1.5 mmol) in CH2Cl2 (~2 ml) was added 
dropwise to an enone 2 (1.5 mmol) dissolved in anhydrous CH2Cl2 (~10 ml). Next, Et3N 
(227 mg, 2.25 mmol) was added, and the reaction mixture was stirred over 12 h. The 
progress of the reaction was controlled via 1H NMR spectroscopy, and if the elimination 
of HBr was not complete, an additional portion of Et3N (227 g, 2.25 mmol) was added. 
The reaction mixture was left over night, then a portion of H2O (~20 ml), was added. 
The organic layer was separated, and the water phase was washed with CH2Cl2 (3x10 
ml). The combined organic layers were dried over anhydrous Na2SO4, filtrated, and the 
solvent was evaporated under reduced pressure. Pure products were isolated by column 
chromatography on SiO2 with petroleum ether with an increasing amount of CH2Cl2 (0–
25%) as an eluent. 
 
(Z)-3-Bromo-4-phenyl-1,1,1-trifluorobut-3-en-2-on (9a).[14b] Yield: 352 mg (84%); 
yellow oil. 1H NMR (600 MHz, CDCl3): δ 8.21 (s, 1H, CH), 7.98–7.96 (m, 2 arom. 
CH), 7.55–7.49 (m, 3 arom. CH) ppm. 13C NMR (150 MHz, CDCl3): δ 175.9 (q, 2JC,F = 
34.5 Hz, C=O), 147.3 (q, 5JC,F = 4.5 Hz, CH), 132.9 (1 arom. C), 132.1, 131.3, 128.8 (5 
arom. CH), 115.8 (q, 1JC,F = 289.5 Hz, CF3), 116.7 (CBr) ppm. 19F NMR (188 MHz, 
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CDCl3): δ –69.09 (s, CF3) ppm. IR (film): v 1714vs (C=O), 1207–1147s (CF3) cm–1. 
ESI-(+)-MS: m/z [M + H]+: 278 (100%), 280 (100%). 
 
(Z)-3-Bromo-4-(4-chlorophenyl)-1,1,1-trifluorobut-3-en-2-on (9b).[4c] Yield: 348 mg 
(74%); yellow crystals, m.p. 83.4–84.2 ºC (without crystallization). 1H NMR (600 MHz, 
CDCl3): δ 7.49–7.47 (m, 2 arom. CH), 7.93–7.90 (m, 2 arom. CH), 8.14 (s, 1H, CH) 
ppm. 13C NMR (150 MHz, CDCl3): δ 175.8 (q, 2JC,F = 34.5 Hz, C=O), 145.7 (q, 5JC,F = 
4.5 Hz, CH), 138.3, 131.2 (2 arom. C), 132.5 129.2 (4 arom. CH), 118.6 (CBr), 115.7 
(q, 1JC,F = 289.5 Hz, CF3) ppm. 19F NMR (188 MHz, CDCl3): δ –69.15 s, CF3) ppm. IR 
(KBr): v 1704vs (C=O), 1204–1157s (CF3) cm–1. ESI-(–)-MS: m/z [M – H]–: 312 (70%), 
314 (100%). 
 
(Z)-3-Bromo-4-(4-methoxyphenyl)-1,1,1-trifluorobut-3-en-2-on (9c).[14b] Yield: 0.394 
mg (85%); orange semi-solid. 1H NMR (600 MHz, CDCl3): δ 8.14 (s, 1H, CH), 8.05–
8.04 (m, 2 arom. CH), 7.01–7.00 (m, 2 arom. CH), 3.90 (s, 3H, CH3) ppm. 13C NMR 
(150 MHz, CDCl3): δ 175.7 (q, 2JC,F = 34.5 Hz, C=O) 163.0, 146.9 (2 arom. C), 134.2, 
114.4 (4 arom. CH), 125.4 (CH), 117.9 (q, 1JC,F = 289.5 Hz, CF3), 113.9 (CBr), 55.5 
(CH3O) ppm. 19F NMR (188 MHz, CDCl3): δ –68.72 (s, CF3) ppm. IR (KBr): v 1701s 
(C=O), 1185–1150s (CF3) cm–1. ESI-(+)-MS: m/z [M + H]+: 309 (97%), 311 (100%). 
 
Synthesis of 1-aryl-4,4,4-trifluorobut-2-en-1-ones 3 
General procedure: 2-Bromo-3,3,3-trifluoropropene (4.7 g, 0.027 mol) was dissolved in 
anhydrous THF (30 ml) and the reaction flask was cooled to –78 oC. Next, a solution of 
LDA, prepared from diisopropylamine (5.4 ml, 0.035 mol) in THF (30 ml) and a 2.5M 
solution of n-BuLi in hexane (14 ml, 0.035 mol) at –78 oC, was added dropwise and the 
mixture was stirred over 15 min. Then, an appropriate aromatic aldehyde (0.015 mol), 
dissolved in THF (~5 ml), was added. The cooling bath was removed and the reaction 
flask was left to reach room temperature. Next, a 1M solution of HCl (50 ml) and 
AcOEt (50 ml) were added. The organic layer was separated and the water layer was 
washed with AcOEt (3x50 ml). The combined organic layer was dried over anhydrous 
Na2SO4, filtrated, and the solvents were removed under reduced pressure. The crude 1-
aryl-4,4,4-trifluorobut-2-yn-1-oles were used for next step without purification. 
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A 1-aryl-4,4,4-trifluorobut-2-yn-1-ol was dissolved in THF (120 ml) and Et3N (6.06 g, 
0.060 mol) was added. The reaction mixture was heated to 60 °C over 12 h in an Ar 
atmosphere. Next, the solvent was removed in rotary evaporator. The products were 
purified by column chromatography on SiO2 with petroleum ether with increasing 
amounts of CH2Cl2 (9:1) as the eluent. The diastereoisomers (E/Z) were not separated. 
 
1-Phenyl-4,4,4-trifluorobut-2-en-1-on (3a).[15b] Yield (for 2 steps): 1.59 g (53%); yellow 
oil. 1H NMR (600 MHz, CDCl3): δ E-isomer: 7.98 (d, 3JH,H = 7.1 Hz, 1H, CH), 6.82 (dq, 
3JH,F = 13.3 Hz, 3JH,H = 7.1 Hz, 1H, CH); Z-isomer: 7.93 (d, 3JH,H = 7.6 Hz, 1H, CH), 
6.09 (dq, 3JH,F = 15.8 Hz, 3JH,H = 7.6 Hz, 1H, CH); both diastereoisomers 7.66–7.64 (m, 
2 arom. CH), 7.55–7.52 (m, 3 arom. CH) ppm. 
 
1-(4-Methoxyphenyl)-4,4,4-trifluorobut-2-en-1-on (3b).[15b] Yield (for 2 steps): 1.41 g 
(41%); yellow oil. 1H NMR (600 MHz, CDCl3): δ E-isomer: 7.99–7.96 (m, 2 arom. 
CH), 7.53 (dq, 4JH,F = 2.0 Hz, 3JH,H = 14.4 Hz, 1H, CH), 7.01–6.89 (m, 2 arom. CH), 
6.79 (dq, 3JH,F = 6.7 Hz, 3JH,H = 14.4 Hz, 1H, CH), 3.90 (s, 3H, CH3O); Z-isomer: 7.91–
7.89 (m, 2 arom. CH), 6.98–6.96 (m, 2 arom. CH), 6.82 (d, 3JH,H = 12.8 Hz, 1H, CH), 
6.04 (dq, 3JH,F = 7.9 Hz, 3JH,H = 12.8 Hz, 1H, CH), 3.89 (s, 3H, CH3O) ppm. 
 
Syntheses of 1-aryl-2-bromo-4,4,4-trifluorobut-2-en-1-ones 10 
General procedure: A solution of Br2 (930 mg, 5.8 mmol) in dry n-hexane (~2 ml) was 
added dropwise to the solution of a fluoroenone 3 (5.8 mmol) in dry n-hexane (30 ml). 
The solution was stirred until disappearance of the red color. Next, a portion of water 
(50 ml) was added, and the mixture was extracted with Et2O (3x25 ml). The organic 
layers were combined and dried over anhydrous Na2SO4, filtered, and the solvents were 
removed under reduced pressure. The crude dibromoderivative was dissolved in Et2O 
(30 ml), Et3N (0.81 g, 8.0 mmol) was added, and the solution was stirred for 24 h. The 
precipitated triethylammonium bromide was filtrated off and the solvent was removed 
under reduced pressure. The product was purified by column chromatography on SiO2 
with petroleum ether with increased amounts of CH2Cl2 (0–25%) as the eluent. 
 
2-Bromo-1-phenyl-4,4,4-trifluorobut-2-en-1-on (10a).[17] Yield: 1.15 g (72%) (single 
diastereoisomer); yellow oil. 1H NMR (600 MHz, CDCl3): δ 7.87–7.86 (m, 2 arom. 
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CH), 7.67–7.65 (m, 1 arom. CH), 7.54–7.51 (m, 2 arom. CH), 6.76 (q, 3JH,F = 6.8 Hz, 
1H, CH) ppm. 13C NMR (150 MHz, CDCl3): δ 188.7 (C=O), 134.4, 130.3, 128.9 (5 
arom. CH), 133.4 (1 arom. C), 130.4 (CBr), 126.9 (q, 2JC,F = 36.6 Hz, CHCF3), 121.4 (q, 
1JC,F = 267.4 Hz, CF3) ppm. 19F NMR (188 MHz, CDCl3): δ –69.93 (d, 3JF,H = 7.2 Hz, 
CF3) ppm. IR (film): v 1685s (C=O), 1242–1150s (CF3) cm–1. ESI-(+)-MS: m/z [M + 
H]+: 279 (100%), 281 (92%). 
 
2-Bromo-1-(4-methoxyphenyl)-4,4,4-trifluorobut-2-en-1-on (10b). Yield: 1.31 g (73%) 
(both diastereoisomers, ratio 7:3); yellow oil. 1H NMR (600 MHz, CDCl3): δ major 
isomer: 7.89–7.87 (m, 2 arom. CH), 6.67 (q, 3JH,F = 6.8 Hz, 1H, CH); minor isomer: 
7.92–7.90 (m, 2 arom. CH), 6.64 (q, 3JH,F = 7.3 Hz, 1H, CH); both isomers 7.00–6.98 
(m, 2 arom. CH), 3.91 (s, 3H, CH3O)ppm. 13C NMR (150 MHz, CDCl3): δ major 
isomer: 187.3 (C=O), 164.8, 125.8 (2 arom. C), 132.4, 114.3 (4 arom. CH), 130.1 (q, 
3JC,F = 6.0 Hz, CBr), 125.3 (q, 2JC,F = 36.0 Hz, CHCF3), 121.5 (q, 1JC,F = 271.5 Hz, CF3), 
55.7 (CH3O); minor isomer: 186.5 (C=O), 165.0, 125.2 (2 arom. C), 132.3, 114.4 (4 
arom. CH), 129.7 (q, 3JC,F = 6.0 Hz, CBr), 122.4 (q, 2JC,F = 36.0 Hz, CHCF3), 121.1 (q, 
1JC,F = 271.5 Hz, CF3), 55.6 (CH3O) ppm. 19F NMR (188 MHz, CDCl3): δ major isomer 
–65.86 (d, 3JF,H = 5.6 Hz, CF3), minor isomer –61.70 (d, 3JF,H = 5.6 Hz, CF3) ppm. IR 
(film): v 1682s (C=O), 1312–1138vs (CF3) cm–1. ESI-(+)-MS: m/z [M + H]+: 309 
(100%), 311 (97%). 
 
Synthesis of β-mercaptoalcohols 11c,d 
1-(Benzyloxy)-3-mercaptopropan-2-ol (11c) 
Obtained following the reported procedure.[13] Yield: 562 mg (89%); yellowish oil. 1H 
NMR (400 MHz, CDCl3): δ 7.38–7.31 (m, 5H), 4.56 (brs, 2H, CH2Ph), 3.88–3.82 (m, 
1H, CHOH), 3.57 (dd, J = 4.5, 9.6 Hz, 1H, CHaHbO), 3.53 (dd, J = 6.1, 9.6 Hz, 1H, 
CHaHbO), 2.75–2.62 (m, 2H, CH2S), 1.44 (t, J = 8.7 Hz, 1H, SH) ppm. 13C NMR (100 
MHz, CDCl3): δ 137.9, 128.4, 127.9, 127.4, 73.3, 72.2, 71.2, 28.1 (CH2S) ppm. EI-MS: 
m/z: 198 (37) [M+·], 122 (45), 107 (73), 91 (100). C10H14O2S (198.28): calcd. C 60.58, 
H 7.12; found: C 60.51, H 7.17. 
 
1-(Allyloxy)-3-mercaptopropan-2-ol (11d) 
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Obtained following reported procedure.[13] Yield: 527 mg (71%); yellowish oil. 1H 
NMR (400 MHz, CDCl3): δ 5.95–5.85 (m, 1H), 5.30–5.19 (m, 2H), 4.04–4.02 (m, 2H, 
CH2OCH=CH2), 3.87–3.81 (m, 1H, CHOH), 3.53 (dd, J = 4.3, 9.5 Hz, 1H, CHaHbO), 
3.49 (dd, J = 6.2, 9.5 Hz, 1H, CHaHbO), 2.74–2.61 (m, 2H, CH2S), 2.39 (brs, 1H, OH), 
1.48 (t, J = 8.7 Hz, 1H, SH) ppm. 13C NMR (100 MHz, CDCl3): δ 134.7, 117.6, 72.6, 
71.1, 70.6, 28.4 (CH2S) ppm. ESI-(+)-MS: m/z [M+Na]+: 171 (100). C6H12O2S 
(148.22): calcd. C 48.62, H 8.16; found: C 48.50, H 8.21. 
 
Reactions of bromoenones 9 and 10 with β-mercaptoalcohols 
General procedure: A β-mercaptoalcohol 11a–d (1 mmol) and Et3N (0.152 g, 1.5 
mmol) were added to a solution of an α-bromoenone 9a–c or 10a,b (1 mmol) in 
anhydrous CH2Cl2 (10 ml). The solution was stirred in an Ar atmosphere for 48 h. Then, 
the solvent was removed under reduced pressure and the product was purified by 
column chromatography on SiO2 with petroleum ether with increased amounts of 
CH2Cl2 (0–100%) as an eluent. 
 
3-Benzylidene-2-(trifluoromethyl)-1,4-oxathian-2-ol (12a). Yield: 136 mg (49%); 
colorless crystals, m.p. 135.8–137.4 ºC (hexane/CH2Cl2). 1H NMR (600 MHz, CDCl3): 
δ 7.56–7.54 (m, 2 arom. CH), 7.41–7.39 (m, 2 arom. CH), 7.34–7.31 (m, 2H, 1 arom. 
CH + CH=C), 4.20–4.17 (m, 1H, CH2), 4.04–4.00 (m, 1H, CH2), 3.26–3.22 (m, 1H, 
CH2), 3.15 (s, 1H, OH), 2.87–2.84 (m, 1H, CH2) ppm.  13C NMR (150 MHz, CDCl3): δ 
135.4 (CH=C), 134.9 (1 arom. C), 129.9, 128.3, 128.1 (5 arom. CH), 123.0 (CH=C), 
122.2 (q, 1JC,F = 285.0 Hz, CF3), 96.7 (q, 2JC,F = 31.5 Hz, CCF3), 60.1 (CH2O), 28.7 
(CH2S) ppm.  19F NMR (188 MHz, CDCl3): δ –84.00 (s, CF3) ppm. IR (KBr): v 
3379br.s (OH), 1188–1141vs (CF3) cm–1. ESI-(–)-MS: m/z: 275 (25%, [M – H]–), 276 
(100%, [M]–). HR-ESI-(–)-MS: 275.0352 (275.0354 calcd. for C12H10F3O2S, [M – H]–). 
 
3-Benzylidene-6-methyl-2-(trifluoromethyl)-1,4-oxathian-2-ol (12b). Yield: 43 mg 
(15%); yellow oil (two diastereoisomers, ratio 96:4). 1H NMR (600 MHz, CDCl3): δ 
7.54–7.53 (m, 2 arom. CH), 7.40–7.39 (m, 2 arom. CH), 7.33–7.30 (m, 2H, 1 arom. CH 
+ CH=C), 4.19–4.14 (m, 1H, CHCH3), 3.10 (s, 1H, OH), 2.95 (dd, 2JH,H = 3JH,H = 11.2 
Hz, 1H, CH2S), 2.83 (dd, 2JH,H = 11.2 Hz, 3JH,H = 6.4 Hz, 1H, CH2S), 1.36 (d, 3JH,H = 
6.2 Hz , 3H, CH3) ppm. 13C NMR (150 MHz, CDCl3): δ 135.1 (1 arom. C), 134.7 
(CH=C), 129.9, 128.2, 128.1 (5 arom. CH), 123.2 (CH=C), 122.1 (q, 1JC,F = 286.1 Hz, 
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CF3), 96.9 (q, 2JC,F = 31.7 Hz, CCF3), 67.0 (CHCH3), 34.6 (CH3), 21.0 (CH2S) ppm. 19F 
NMR (188 MHz, CDCl3): δ major isomer –84.45 (s, CF3); minor isomer –80.32 (s, CF3) 
ppm. IR (film): v 3443br.s (OH), 1188–1097vs (CF3) cm–1. ESI-(+)-MS: m/z 273 
(100%, [M–OH]+). HR-ESI-(–)-MS: 289.0506 (289.0510 calcd. for C13H12F3O2S, [M – 
H]–).  
 
3-Benzylidene-6-(benzyloxymethyl)-2-(trifluoromethyl)-1,4-oxathian-2-ol (12c). Yield: 
149 mg (38%); yellow oil (two diastereoisomers, ratio 90:10). 1H NMR (600 MHz, 
CDCl3): δ 7.55–7.54 (m, 2 arom. CH), 7.40–7.29 (m, 9H, 8 arom. CH + CH=C), 4.58 (s, 
1H, OH), 4.59–4.54 (m, 2H, CH2Ph), 4.25–4.23 (m, 1H, CHCH2OBn), 3.66 (dd, 2JH,H = 
10.5 Hz, 3JH,H = 6.1 Hz, 1H, CHCH2OBn), 3.53 (dd, 2JH,H = 10.5 Hz, 3JH,H = 4.6 Hz, 
1H, CHCH2O), 3.01 (dd, 2JH,H = 3JH,H = 11.3 Hz, 1H, CH2S), 2.89 (dd, 2JH,H = 11.3 Hz, 
3JH,H = 2.9 Hz, 1H, CH2S) ppm. 13C NMR (150 MHz, CDCl3): δ 137.7 (CH=C) , 135.3, 
135.0 (2 arom. C), 129.9, 128.5, 128.3, 128.0, 127.9, 127.7 (10 arom. CH), 123.3 
(CH=C), 122.1 (q, 1JC,F = 285.0 Hz, CF3), 97.0 (q, 2JC,F = 31.6 Hz, CCF3), 73.5, 71.5, 
69.6 (2CH2 + CH), 30.6 (CH2S) ppm. 19F NMR (188 MHz, CDCl3): δ major isomer –
83.55 (s, CF3); minor isomer –80.47 (s, CF3) ppm. IR (film): v 3357br.s (OH), 1198–
1112vs (CF3) cm–1. ESI-(+)-MS: m/z 419.1 (100%, [M + Na]+), 435 (49%, [M + K]+). 
HR-ESI-(+)-MS: 419.0898 (419.0905 calcd. for C20H19F3O3SNa, [M + Na]+). 
 
6-(Allyloxymethyl)-3-benzylidene-2-(trifluoromethyl)-1,4-oxathian-2-ol (12d). Yield: 92 
mg (27%); yellow oil (two diastereoisomers, ratio 91:9). 1H NMR (600 MHz, CDCl3): δ 
7.55–7.53 (m, 2 arom. CH), 7.41–7.38 (m, 2 arom. CH), 7.33–7.32 (m, 2H, 1 arom. CH 
+ CH=C), 5.92–585 (m, 1H, CH=CH2), 5.30–5.27 (m, 1H, CH=CH2); 5.22–5.20 (m, 
1H, CH=CH2), 4.21–4.17 (m, 1H, CHCH2O), 4.05–4.04 (m, 2H, OCH2CH=CH2), 3.64 
(dd, 2JH,H = 10.6 Hz, 3JH,H = 6.2 Hz, 1H, CHCH2O), 3.10 (dd, 2JH,H = 10.6 Hz, 3JH,H = 
4.6 Hz, 1H, CHCH2O), 3.49 (s, 1H, OH), 3.00 (dd, 2JH,H = 3JH,H = 11.2 Hz, 1H, CH2S), 
2.89 (dd, 2JH,H = 11.2 Hz, 3JH,H = 3.0 Hz, 1H, CH2S) ppm. 13C NMR (150 MHz, 
CDCl3): δ 135.4, 135.0 (2CH=C), 134.3 (1 arom. C), 129.9, 128.3, 128.1 (5 arom. CH), 
123.3 (CH=C-S), 120.1 (q, 1JC,F = 285.0 Hz, CF3), 117.5 (CH=CH2), 97.0 (q, 2JC,F = 
31.9 Hz, CCF3), 72.5, 71.5, 69.6 (2CH2 + CH), 30.6 (CH2S) ppm. 19F NMR (188 MHz, 
CDCl3): δ major isomer –83.57 (s, CF3); minor isomer –80.46 (s, CF3) ppm. IR (film): v 
3341br.s (OH), 1198–1100vs (CF3) cm–1. ESI-(–)-MS: m/z: 345.3 (100%, [M – H]–); 
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346 (97%, [M]–). HR-ESI-(+)-MS: 369.0737 (369.0748 calcd. for C16H17F3O3SNa, 
[M+Na]+) 
 
3-(4-Chlorobenzylidene)-2-(trifluoromethyl)-1,4-oxathian-2-ol (12e). Yield: 146 mg 
(47%); colorless crystals, m.p. = 143.1–145.8 ºC (hexane/CH2Cl2). 1H NMR (600 MHz, 
CDCl3): δ 7.50–7.48 (m, 2 arom. CH), 7.37–7.35 (m, 2 arom. CH), 7.27 (s, 1H, CH), 
4.21–4.18 (m, 1H, CH2), 4.03–3.98 (m, 1H, CH2), 3.27–3.23 (m, 1H, CH2), 3.15 (s, 1H, 
OH), 2.88–2.85 (m, 1H, CH2) ppm. 13C NMR (150 MHz, CDCl3): δ 134.1, 134.0 
(CH=C + 1 arom. C), 133.4 (1 arom. C), 131.1, 128.3 (4 arom. CH), 123.8 (CH=C), 
122.1 (q, 1JC,F = 286.2 Hz, CF3), 96.6 (q, 2JC,F = 31.8 Hz, CCF3), 60.1 (CH2O), 28.7 
(CH2S) ppm.  19F NMR (188 MHz, CDCl3): δ –84.06 (s, CF3) ppm. IR (KBr): v 
3405br.s (OH), 1192–1144vs (CF3) cm–1. ESI-(–)-MS: m/z 309 (100%, [M – H]–), 310 
(80%, [M]–). HR-ESI-(–)-MS: 308.9961 (308.9964 calcd. for C12H9F3O2SCl, [M – H]–). 
 
3-(4-Methoxybenzylidene)-2-(trifluoromethyl)-1,4-oxathian-2-ol (12f). Yield: 52 mg 
(17%); colorless crystals, m.p. 102.7–104.2 ºC (hexane/CH2Cl2). 1H NMR (600 MHz, 
CDCl3): δ 7.54–7.52 (m, 2 arom. CH), 7.27 (s, 1H, CH), 6.93–6.92 (m, 2 arom. CH), 
4.19–4.16 (m, 1H, CH2), 4.03–3.99 (m, 1H, CH2), 3.84 (s, 3H, CH3O), 3.24–3.22 (m, 
1H, CH2), 3.11 (br.s, 1H, OH), 2.87–2.85 (m, 1H, CH2) ppm.  13C NMR (150 MHz, 
CDCl3): δ 159.6 (1 arom. C), 135.1 (CH=C), 131.5, 113.5 (4 arom. CH), 127.7 (1 arom. 
C), 122.2 (q, 1JC,F = 286.5 Hz, CF3), 120.4 (CH=C), 96.8 (q, 2JC,F = 31.5 Hz, CCF3), 
60.0 (CH2O), 55.3 (CH3O), 28.7 (CH2S). 19F NMR (188 MHz, CDCl3): δ –84.02 (s, 
CF3) ppm. IR (KBr): v 3383br.s (OH), 1195–1144vs (CF3) cm–1. ESI-(+)-MS: m/z: 
307.1 (100%, [M + H]+). HR-ESI-(–)-MS: 305.0454 (305.0459 calcd. for C13H12F3O3S, 
[M – H]–). 
 
1-Phenyl-2-[(2-trifluoromethyl)-1,3-oxathiolan-2-yl]ethan-1-on (13). Yield: 164 mg 
(59%); yellow oil. 1H NMR (600 MHz, CDCl3): δ 7.96–7.95 (m, 2 arom. CH), 7.60–
7.57 (m, 1 arom. CH), 7.49–7.46 (m, 2 arom. CH), 4.29–4.19 (m, 2H, CH2O), 3.66, 3.63 
(AB, 2JH,H = 16.3 Hz, 2H, CH2), 3.15–3.06 (m, 2H, CH2S) ppm.  13C NMR (150 MHz, 
CDCl3): δ 194.1 (C=O), 137.3 (1 arom. C), 133.4, 128.6 (5 arom CH), 124.9 (q, 1JC,F = 
283.5 Hz, CF3), 92.0 (q, 2JC,F = 30.0 Hz, CCF3), 73.9 (CH2O), 42.2 (CH2), 33.8 (CH2S) 
ppm.  19F NMR (188 MHz, CDCl3): δ –79.77 (s, CF3) ppm. IR (film): v 1698s (C=O), 
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1220–1119s (CF3) cm–1. ESI-(+)-MS: m/z 277 (85%, [M + H]+). HR-ESI-(–)-MS:: 
308.9961 (308.9964 calcd. for C12H9F3O2SCl, [M – H]–). 
 
3-[(2-Hydroxyethyl)sulfanyl)]-1-(4-methoxyphenyl)-4,4,4-trifluorobutan-1-on (14a). 
Yield: 233 mg (76%); orange oil. 1H NMR (600 MHz, CDCl3): δ 7.97–7.94 (m, 2 arom. 
CH), 6.97–6.95 (m, 2 arom. CH), 4.08–4.04 (m, 1H, CHS), 4.00–3.95 (m, 1H, CH2O), 
3.89 (s, 3H, CH3O), 3.88–3.83 (m, 1H, CH2O), 3.91–3.30 (m, 3H, CH2 + OH), 3.06–
3.02 (m, 1H, CH2S), 2.82–2.77 (m, 1H, CH2S) ppm. 13C NMR (150 MHz, CDCl3): δ 
193.9 (C=O), 164.3, 129.1 (2 arom. C), 127.2 (q, 1JC,F = 276.2 Hz, CF3), 130.7, 114.0 (4 
arom. CH), 61.3 (CH2O), 55.6 (CH3O), 41.8 (q, 2JC,F = 29.6 Hz, CHCF3), 37.5 (CH2), 
36.5 (CH2S) ppm. 19F NMR (188 MHz, CDCl3): δ –72.28 (d, 3JF,H = 8.3 Hz, CF3) ppm. 
IR (film): v 3458br.s (OH), 1676vs (C=O), 1263–1174vs (CF3) cm–1.  ESI-(+)-MS: m/z: 
309 (100%, [M + H]+). HR-ESI-(+)-MS: 331.0583 (331.0592 calcd. for 
C13H15F3O3SNa, [M + Na]+). 
 
3-[(3-Benzyloxy-2-hydroxypropyl)sulfanyl]-1-phenyl-4,4,4-trifluorobutan-1-on (14b). 
Yield: 135 mg (34%) (two diastereoisomers, ratio 1:1); orange oil. 1H NMR (600 MHz, 
CDCl3): δ 7.97–7.88 (m, arom. CH), 7.64–7.61 (m, arom. CH), 7.52–7.49 (m), 7.37–
7.33 (m, arom. CH), 7.31–7.28 (m, arom. CH), 4.60–4.55 (m), 4.18–4.12 (m), 4.09–4.02 
(m), 3.62–3.55 (m), 3.45–3.38 (m), 3.22 (d, J = 6.0 Hz), 3.07 (dd, J(1) = 13.8 Hz, J(2) = 
4.2 Hz), 2.90 (d, J = 6.6 Hz), 2.83 (dd, J(1) = 13.8 Hz, J(2) = 6.6 Hz) ppm (a complex set 
of signals, it was impossible to attribute them to particular diastereoisomer). 13C NMR 
(150 MHz, CDCl3): δ 195.3, 195.2 (C=O), 138.0, 137.9, 136.1, 136.0 (2 arom. C), 
134.0, 133.9, 128.8, 128.4, 128.3, 128.2, 127.8, 127.75, 127.7 (10 arom. CH), 127.2, 
127.1 (2q, 1JC,F = 276.0 Hz, CF3), 73.5, 72.7, 72.3, 71.2, 68.7 (HOCH, CH2O, CH2Ph), 
43.1, 42.3 (q, 2JC,F = 28.5 Hz, CHCF3), 38.2, 38.0 (CH2), 37.2, 37.0 (CH2S) ppm. 19F 
NMR (188 MHz, CDCl3): δ –71.39 and –71.16 (2d, ratio 1:1, 3JF,H = 8.3 Hz for both 
doublets, CF3 for two diastereoisomers) ppm. IR (film): v 3455br.s (OH), 1692vs 
(C=O), 1252–1154vs (CF3) cm–1. ESI-(+)-MS: m/z: 421 (100%, [M + Na]+). HR-ESI-
(+)-MS: 421.1049 (421.1061 calcd. for C20H21F3O3SNa, [M + Na]+). 
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